239 related articles for article (PubMed ID: 31651326)
1. High expression of FABP4 and FABP6 in patients with colorectal cancer.
Zhang Y; Zhao X; Deng L; Li X; Wang G; Li Y; Chen M
World J Surg Oncol; 2019 Oct; 17(1):171. PubMed ID: 31651326
[TBL] [Abstract][Full Text] [Related]
2. High expression of FABP4 in colorectal cancer and its clinical significance.
Zhang Y; Zhang W; Xia M; Xie Z; An F; Zhan Q; Tian W; Zhu T
J Zhejiang Univ Sci B; 2021 Feb; 22(2):136-145. PubMed ID: 33615754
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid binding protein 6 is overexpressed in colorectal cancer.
Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M
Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognostic implication of nuclear fatty acid-binding protein 4 expression in colorectal cancer.
Kim SH; Pyo JS; Son BK; Oh IH; Min KW
Pathol Res Pract; 2023 Sep; 249():154722. PubMed ID: 37591068
[TBL] [Abstract][Full Text] [Related]
5. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
7. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
9. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
10. FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells.
Lian W; Wang Z; Ma Y; Tong Y; Zhang X; Jin H; Zhao S; Yu R; Ju S; Zhang X; Guo X; Huang T; Ding X; Peng M
J Immunol Res; 2022; 2022():3129765. PubMed ID: 36033394
[TBL] [Abstract][Full Text] [Related]
11. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
Wang P; Li C; Ma X; Gai X
Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
Wang P; Li C; Zhang F; Ma X; Gai X
Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
[TBL] [Abstract][Full Text] [Related]
15. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
Ding D; Yao Y; Yang C; Zhang S
Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
17. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
19. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
[TBL] [Abstract][Full Text] [Related]
20. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
